Catalyst Pharmaceuticals Gears Up for Key Investor Engagements

Exciting Investor Conferences Ahead for Catalyst Pharmaceuticals

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a dynamic biopharmaceutical company, is preparing to showcase its pioneering efforts in developing treatments for rare and hard-to-treat diseases. With a focus on in-licensing and commercializing novel therapeutics, Catalyst is making significant strides in the medical community.

Key Presentations Planned

As part of its commitment to maintaining transparency and engaging with investors, the President and CEO of Catalyst, Richard J. Daly, along with select members of the management team, will be attending several high-profile investor conferences in the upcoming weeks.

Wells Fargo Healthcare Conference Details

The first on the calendar is the Wells Fargo Healthcare Conference. Scheduled for September 3, 2025, Catalyst will be presenting at 2:15 PM ET. This conference presents a valuable opportunity for the company to connect with key stakeholders in the healthcare sector.

Cantor Global Healthcare Conference Insights

Another notable event is the Cantor Global Healthcare Conference on September 4, 2025, at 3:20 PM ET. Catalyst will provide insights into its ongoing projects and future direction, reinforcing its commitment to addressing urgent healthcare needs.

H.C. Wainwright Global Investment Conference

On September 8, 2025, Catalyst will be present at the H.C. Wainwright 27th Annual Global Investment Conference, with a presentation set for 9:00 AM ET. This event is anticipated to foster meaningful discussions on the company’s financial outlook and potential growth strategies.

Baird Global Conference Highlights

The Baird Global Conference on September 9, 2025, at 12:50 PM ET, rounds out the series of conferences Catalyst will attend. Each of these forums is crucial for displaying Catalyst's work and garnering interest from the investment community.

Accessing Conference Webcasts

For those interested in tuning in, webcasts from these conferences will be accessible through the Investor Relations section of Catalyst's official website. Highlights and replays will be available for a minimum of 30 days following the events, ensuring that stakeholders can remain informed on Catalyst’s developments.

About Catalyst Pharmaceuticals

Founded with a mission to enhance the quality of life for individuals with rare diseases, Catalyst Pharmaceuticals, Inc. has established itself as a leader in the biopharmaceutical industry. The company is recognized for its unwavering dedication to patient care and strives to make essential treatments accessible to those who need them most. The headquarters in Coral Gables plays a pivotal role in its operations and commercial strategies.

In recent accomplishments, Catalyst was highlighted on prestigious lists, including Forbes' ranking of America’s Most Successful Mid-Cap Companies and the Deloitte Technology Fast 500™ as one of North America's Fastest-Growing Companies.

Contact Information

For further inquiries, investors can reach out to:

Investor Contact:
Mary Coleman, Catalyst Pharmaceuticals, Inc.
(305) 420-3200
IR@catalystpharma.com

Media Contact:
David Schull, Russo Partners
(858) 717-2310
david.schull@russopartnersllc.com

Frequently Asked Questions

What is Catalyst Pharmaceuticals known for?

Catalyst Pharmaceuticals focuses on developing treatments for rare and difficult-to-treat diseases.

When will Catalyst participate in investor conferences?

Catalyst will participate in several conferences throughout September 2025, with presentations on different dates.

How can I access Catalyst's conference webcasts?

Webcasts will be available in the Investor Relations section of Catalyst’s website for at least 30 days after each event.

Who should I contact for investor inquiries?

Mary Coleman from Catalyst's team is the designated contact for investor inquiries.

What recognition has Catalyst received recently?

Catalyst has been recognized on lists highlighting successful mid-cap companies and fastest-growing technology firms.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.